How many insider declarations has Viehbacher Christopher filed?

Viehbacher Christopher has filed 4 public insider declarations with SEC (Form 4).

What is Viehbacher Christopher's role?

Viehbacher Christopher's reported role is not specified by the regulator across the filings.

Which companies does Viehbacher Christopher report trades for?

Viehbacher Christopher reports trades for 2 companies, including BIOGEN INC..

What is Viehbacher Christopher's declared buy vs sell volume?

Across the available history, declared buys total 1.3M€ and disposals 0.

← Executives ★ Sign in to follow

VC

Viehbacher Christopher

CEO

·SEC (Form 4)

BIOGEN INC.Braveheart Bio, Inc.

0

申报总数

0

公司

€130万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Viehbacher Christopher. Officer active across 2 companies, notably BIOGEN INC.. In total, 4 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €1.3m. History available since 7 February 2025. The latest transaction was disclosed on 7 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Viehbacher Christopher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

BIOGEN INC. (US)Braveheart Bio, Inc. (US)

申报4 总计

▲

Viehbacher Christopher

Director高管2026年8月7日Braveheart Bio, Inc.

US$150万0SEC ↗

83,333 股@ US$18.00Common StockSEC:0001470831-26-000801:0

标准退出：2026年11月5日 (T+90)

◇

Viehbacher Christopher

President and CEO高管2026年2月6日BIOGEN INC.

0SEC ↗

9,008 股0Common StockSEC:0000875045-26-000024:0

◇

Viehbacher Christopher

President and CEO高管2025年12月1日BIOGEN INC.

0SEC ↗

7,040 股0Common StockSEC:0000875045-25-000052:0

◇

Viehbacher Christopher

President and CEO高管2025年2月7日BIOGEN INC.

0SEC ↗

9,008 股0Common StockSEC:0001127602-25-003962:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

VC

Viehbacher Christopher

CEO

·SEC (Form 4)

BIOGEN INC.Braveheart Bio, Inc.

0

申报总数

0

公司

€130万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Viehbacher Christopher. Officer active across 2 companies, notably BIOGEN INC.. In total, 4 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €1.3m. History available since 7 February 2025. The latest transaction was disclosed on 7 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.